Cargando…
Affinity-enhanced T-cell receptors for adoptive T-cell therapy targeting MAGE-A10: strategy for selection of an optimal candidate
Circulating T-cells that have passed thymic selection generally bear T-cell receptors (TCRs) with sub-optimal affinity for cancer-associated antigens, resulting in a limited ability to detect and eliminate tumor cells. Engineering TCRs to increase their affinity for cancer targets is a promising str...
Autores principales: | Border, Ellen C., Sanderson, Joseph P., Weissensteiner, Thomas, Gerry, Andrew B., Pumphrey, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343776/ https://www.ncbi.nlm.nih.gov/pubmed/30713784 http://dx.doi.org/10.1080/2162402X.2018.1532759 |
Ejemplares similares
-
Preclinical safety testing of an affinity-optimised MAGE-A10 T cell receptor for adoptive T cell therapy
por: Gerry, Andrew, et al.
Publicado: (2015) -
Structural insights into engineering a T-cell receptor targeting MAGE-A10 with higher affinity and specificity for cancer immunotherapy
por: Simister, Philip C, et al.
Publicado: (2022) -
Preclinical evaluation of an affinity-enhanced MAGE-A4-specific T-cell receptor for adoptive T-cell therapy
por: Sanderson, Joseph P, et al.
Publicado: (2019) -
Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer
por: Docta, Roslin Y., et al.
Publicado: (2019) -
Improved affinity AFP-specific T cell receptor for hepatocellular carcinoma
por: Gerry, Andrew B, et al.
Publicado: (2013)